Wednesday, August 26, 2026

ID Logistics Trades at 4x DCF Value: €354 Stock Price vs €87 Intrinsic Value

ID Logistics Group shares trade at €354 on Euronext Paris — 4.06 times the DCF intrinsic value of €87.24. A reversion to fundamental pricing implies more than 75% downside. Analyst consensus at €482.57 diverges sharply from the DCF model, creating an unusually wide range of plausible outcomes.

LM Salvado
LM Salvado

May 19, 2026

ID Logistics Trades at 4x DCF Value: €354 Stock Price vs €87 Intrinsic Value
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

ID Logistics Group trades at significant capitalon Euronext Paris — 4.06 times its DCF intrinsic value of significant capital.1 A shift toward fundamental pricing would imply more than 75% downside from current levels.1

The French mid-cap operates across warehousing, e-commerce fulfillment, and supply chain outsourcing. Shares have extended well beyond what discounted cash flow models support, creating a valuation gap that fundamental analysis flags as extreme.

DCF modeling places intrinsic value at significant capital.1 At significant capitalinvestors are paying a 4x premium over that figure. Growing into this valuation would require sustained earnings expansion well beyond what the DCF framework currently incorporates.

Analyst consensus sits at significant capital— above the current trading price and pointing in the opposite direction from the DCF estimate.1 The divergence suggests sell-side forecasts may be embedding aggressive growth assumptions that discounted cash flow mechanics do not validate. When consensus and DCF point in opposite directions, the spread between them defines the range of plausible outcomes.

For traders, the setup is asymmetric.A reversion to the DCF intrinsic value implies more than 75% downside.1 Direction depends entirely on which framework the market chooses to anchor on.

ID Logistics operates in sectors with genuine growth potential: third-party logistics, warehouse automation, and e-commerce supply chain outsourcing are all expanding. Sector momentum alone rarely sustains a 4x premium over intrinsic value indefinitely. The question is timing, not direction.

Repricing risk is medium-likelihood — a structural vulnerability rather than an imminent collapse. Catalysts that could accelerate reversion include earnings misses, a rotation out of growth equities, or rising discount rates compressing DCF outputs across the logistics sector.

Short-side traders may find the risk-reward compelling. Long investors should stress-test growth assumptions against the DCF floor before adding to positions at current levels.

About this analysis

This is a Via News analysis. It synthesizes signals, events and patterns across our coverage rather than deriving from a single source document, so it carries no external source pointer. Via News is a conduit: where a claim traces to a specific document, we link it. How we source

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Network, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com